Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Sinopharm Affiliate Pays $50 Million for Oramed's Oral Insulin Product

publication date: Nov 30, 2015
Hefei Tianhui Incubator of Technologies signed a $50 million agreement for exclusive China rights to a clinical stage oral insulin product developed by Jerusalem's Oramed Pharma. HTIT is partially owned by Sinopharm Group. The deal includes a $12 million investment by HTIT in Oramed (giving it a 9% stake), a $3 million upfront payment and $8 million in near-term payments. The rest is for milestones, and HTIT will also pay a 10% royalty, which Oramed said could make a significant impact on its earnings, given China's large population of diabetes patients. More details....

Stock Symbol: (NSDQ: ORMP)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here